| Type | Title | Date Released | |
|---|---|---|---|
SCHEDULE 13D/A | SINO LION VENTURES Ltd (Filed by) | ||
SCHEDULE 13D/A | Dai Junyi (Filed by) | ||
SCHEDULE 13D/A | Yao Yun (Filed by) | ||
SCHEDULE 13D/A | Yang Ting (Filed by) | ||
8-K | Private Placement Closes, Raising Approximately $24 Million Through Issuance of 20.3 Million Common Shares | ||
S-8 | Form S-8 | ||
8-K | Indaptus Therapeutics Extends Private Placement Closing Deadline to October 16, 2026 | ||
8-K | Indaptus Therapeutics Enters into Private Placement Agreement for Approximately $24.0 Million in Gross Proceeds | ||
8-K/A | Company Amends At the Market Offering Agreement, Authorizing Up to $100 Million in Common Stock Sales | ||
8-K | Indaptus Therapeutics Announces Resignation of Director Tim Ruan | ||
424B5 | [No Baby Shelf]* September 2026 ATM | Offering amount: $100,000,000 | Bank: H.C. Wainwright & Co. | ||
8-K | Indaptus Therapeutics Enters into New $100 Million At-the-Market Offering Agreement |
